Company
Every investor coverage indicates participated in a round ResMed raised.
Companies ResMed acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
| Name | Role | Sources |
|---|---|---|
| Dr Chris Roberts | Non-executive Director | SmartCompany |
| Dr Chris Roberts AO | Director | Startup Daily |
| Dr Chris Roberts AO | Non-Executive Director and Executive VP (former) | @AuManufacturing |
| Justin Leong | Chief Product Officer | @AuManufacturing |
| Mark Sproule | Mechanical Engineer (former) | @AuManufacturing |
| Peter Farrell | Chair | Forbes Australia |
Stories naming ResMed. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Bioshore Ventures has wrapped up its first fund at $27 million with all capital committed, drawing 65 individual backers including three well-known investors, and has named four health-technology companies in its portfolio.
An analysis of what Australian long-horizon research commercialisation requires, citing Gilmour Space, Cochlear and BluGlass as illustrations of patient capital and ecosystem support needs.
Ten13's post explains why it joined the robotics company's latest raise alongside Blackbird, Neotribe, Startmate and Horizons, covering its autonomous scanning device, dialysis focus, founders, and US rollout plans.
Roundup of manufacturing news: Archer Materials' biochip results with IMEC, Resmed's CPAP mask launch, Boeing's RAAF P-8A upgrades, Breakthrough Victoria's $75m across venture funds, an Avalon Airport freight facility, and Sleeptite's FlexiSense.
Startup Daily and Cicada Innovations profile five health-focused deep tech startups selected for the August Cicada x Tech23 event in Sydney; one founder recalls earlier angel and VC fundraising.
Weekly roundup covering six startup raises: ImmVirX, Nutromics, Nuheara, Autism 360, Cogo and Gather, plus Nutromics' 30X30 selection, a board appointment and Viralytics' earlier sale to Merck.
Wearable diagnostics developer Nutromics has raised $11 million from two unnamed family offices, after a prior $20 million round backed by Dexcom's venture arm, and appointed Dr Chris Roberts as non-executive chairperson.
Also SmartCompany·Techboard
Profile of SYMBYX, an Australian medtech firm using light therapy lasers to ease Parkinson's symptoms, naming its high-profile investors including ResMed's Peter Farrell and noting clinical trials underway.
Profile of Sydney underwater robotics maker Blueprint Lab, which won an Australian space agency grant and, its CEO says, is being acquired by London's General Oceans.
AFR healthcare and fitness section roundup: Early Bird raised $2 million led by Hyper Ventures; Resmed sold MatrixCare; Radiopharm seeks $16 million; plus Mayne Pharma, Healthscope, Sigma and policy stories.
Also SmartCompany